CLOV - NASDAQ
Clover Health Investments, Corp.
$3.96
+8.6%Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.
At a Glance
Live SnapshotClover Health Investments, Corp. Management Team
Ms. Wendy Richey
Chief Compliance Officer
Mr. Conrad Wai
Chief Executive Officer of Counterpart Health
Compensation
$1,466,847
Mr. Brady Priest J.D.
Chief Executive Officer of Home Care
Compensation
$1,455,970
Ms. Jamie L. Reynoso
Chief Executive Officer of Medicare Advantage
Compensation
$1,793,296
Mr. Peter J. Kuipers
Chief Financial Officer
Compensation
$367,213
Dr. Kumar Dharmarajan
Chief Medical Officer of Clover Assistant
Ms. Rachel Fish
Chief People Officer
Mr. Vivek Garipalli
Co-Founder & Executive Chairman
Mr. Andrew Toy
Co-Founder, Chief Executive Officer & Director
Compensation
$1,585,003
Ms. Karen Soares
General Counsel, Senior Vice President & Corporate Secretary
Compensation
$513,197
Clover Health Investments, Corp. Insider Positioning
During the last 12 months, insiders have sold $2.29M worth of CLOV shares, with no buying activity reported.
3 Months
0
0.00
391.5K
1.47M
-1.5M
-$1.47M
3-6 Months
0
0.00
186.6K
409.75K
-410K
-$410K
6-9 Months
0
0.00
117.0K
414.51K
-415K
-$415K
9-12 Months
0
0.00
0
0.00
+0
+$0
Top Buyers
No buying activity
Top Sellers
Priest Brady Patrick
Officer: Ceo Of Clover Care Services
$1.03M
Wai Conrad
Officer: Ceo, Counterpart Health
$879K
Edwards Carladenise Armbrister
Director
$230K
Reynoso Jamie L.
Officer: Ceo, Medicare Advantage
$150K
Insider Activity Analysis
Net Insider Sentiment
Strong bearish signal with $2.29M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.
Buy/Sell Ratio
Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.
Recent Trend (3 Months)
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
Insider Participation
4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.
Insider Activity Insight
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
SEC Filings
CLOV - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | April 28, 2026 | April 28, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | April 28, 2025 | April 28, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | April 26, 2024 | April 26, 2024 | 2024 | |
DEF 14A DEF 14A 2023 N/A | July 21, 2023 | August 30, 2023 | 2023 | |
DEF 14A DEF 14A N/A | April 26, 2023 | April 26, 2023 | ||
DEF 14A DEF 14A 2022 N/A | August 12, 2022 | September 22, 2022 | 2022 |
Research Paths
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.